A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies. - Trivedi, Neel D.; Armstrong, Samantha; Wang, Hongkun; Hartley, Marion; Deeken, John; Ruth He, A.; Subramaniam, Deepa; Melville, Heather; Albanese, Chris; Marshall, John L.; Hwang, Jimmy; Pishvaian, Michael J. (Cancer Medicine, 2021)